Delivery Order SPE2DB22D2206-SPE2DB25FGN94
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,767.78 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of XCOPRI 100 MG TABLET 30S. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026 for providing a wide range of pharmaceutical products and medical supplies to...
This is a $3,536.88 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company. The contract is for the supply of XCOPRI 150 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of December 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,768.44 firm-fixed-price contract is for the supply of XCOPRI 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $2,357.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $1,767.72 and is a firm fixed-price delivery order, with a period of performance through May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,768.44, is for the delivery of XCOPRI 150 MG TABLET 30S, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a specialty pharmaceutical product, with a ceiling value of $2,357.92 and a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,699.87, is for the delivery of XCOPRI 200 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen has previously been awarded an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,178.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4568175836 - XCOPRI 150 MG TABLET 30S, a pharmaceutical product. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a $1,224.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XCOPRI 50 MG TABLET 30S. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, AmerisourceBergen provides a comprehensive range of pharmaceutical products and...